<VariationArchive RecordType="classified" VariationID="929298" VariationName="NM_001139.3(ALOX12B):c.1275+30_1275+35del" VariationType="Deletion" Accession="VCV000929298" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2020-06-27" MostRecentSubmission="2020-06-27">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="917585" VariationID="929298">
      <GeneList>
        <Gene Symbol="ALOX12B" FullName="arachidonate 12-lipoxygenase, 12R type" GeneID="242" HGNC_ID="HGNC:430" Source="calculated" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="8072636" stop="8087716" display_start="8072636" display_stop="8087716" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7975953" stop="7991020" display_start="7975953" display_stop="7991020" Strand="-" />
          </Location>
          <OMIM>603741</OMIM>
        </Gene>
        <Gene Symbol="SNORD118" FullName="small nucleolar RNA, C/D box 118" GeneID="727676" HGNC_ID="HGNC:32952" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>17p13.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="8173452" stop="8173588" display_start="8173452" display_stop="8173588" Strand="-" />
          </Location>
          <OMIM>616663</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001139.3(ALOX12B):c.1275+30_1275+35del</Name>
      <CanonicalSPDI>NC_000017.11:8076954:ATGCCT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17p13.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="8076955" stop="8076960" display_start="8076955" display_stop="8076960" variantLength="6" positionVCF="8076954" referenceAlleleVCF="GATGCCT" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="7980273" stop="7980278" display_start="7980273" display_stop="7980278" variantLength="6" positionVCF="7980272" referenceAlleleVCF="GATGCCT" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.7980273_7980278del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.7980273_7980278del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.8076955_8076960del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.8076955_8076960del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007099.1" sequenceAccession="NG_007099" sequenceVersion="1" change="g.15744_15749del">
            <Expression>NG_007099.1:g.15744_15749del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007099.2" sequenceAccession="NG_007099" sequenceVersion="2" change="g.15757_15762del">
            <Expression>NG_007099.2:g.15757_15762del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001139.3" sequenceAccession="NM_001139" sequenceVersion="3" change="c.1275+30_1275+35del" MANESelect="true">
            <Expression>NM_001139.3:c.1275+30_1275+35del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1264" sequenceAccession="LRG_1264">
            <Expression>LRG_1264:g.15757_15762del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1264t1" sequenceAccession="LRG_1264t1">
            <Expression>LRG_1264t1:c.1275+30_1275+35del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1977098048" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001139.3(ALOX12B):c.1275+30_1275+35del AND Leukoencephalopathy with calcifications and cysts" Accession="RCV001194511" Version="1">
        <ClassifiedConditionList TraitSetID="32665">
          <ClassifiedCondition DB="MedGen" ID="C3281200">Leukoencephalopathy with calcifications and cysts</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-04-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-04-06" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-06-27" MostRecentSubmission="2020-06-27">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="32665" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16872" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Leukoencephalopathy with calcifications and cysts</ElementValue>
                <XRef ID="MONDO:0013803" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">LABRUNE SYNDROME</ElementValue>
                <XRef Type="MIM" ID="614561" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leukoencephalopathy, brain calcifications, and cysts</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">LCC</ElementValue>
                <XRef Type="MIM" ID="614561" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Leukoencephalopathy, brain calcifications, and cysts (LCC), also known as Labrune syndrome, is characterized by a constellation of features restricted to the central nervous system, including leukoencephalopathy, brain calcifications, and cysts, resulting in spasticity, dystonia, seizures, and cognitive decline (summary by Labrune et al., 1996).
See also cerebroretinal microangiopathy with calcifications and cysts (CRMCC; 612199), an autosomal recessive disorder caused by mutation in the CTC1 gene (613129) that shows phenotypic similarities to Labrune syndrome. CRMCC includes the neurologic findings of intracranial calcifications, leukodystrophy, and brain cysts, but also includes retinal vascular abnormalities and other systemic manifestations, such as osteopenia with poor bone healing, a high risk of gastrointestinal bleeding, hair, skin, and nail changes, and anemia and thrombocytopenia. Although Coats plus syndrome and Labrune syndrome were initially thought to be manifestations of the same disorder, namely CRMCC, molecular evidence has excluded mutations in the CTC1 gene in patients with Labrune syndrome, suggesting that the 2 disorders are not allelic (Anderson et al., 2012; Polvi et al., 2012).</Attribute>
                <XRef Type="MIM" ID="614561" DB="OMIM" />
              </AttributeSet>
              <XRef ID="542310" DB="Orphanet" />
              <XRef ID="C3281200" DB="MedGen" />
              <XRef ID="MONDO:0013803" DB="MONDO" />
              <XRef Type="MIM" ID="614561" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2691558" SubmissionDate="2020-04-06" DateLastUpdated="2020-06-27" DateCreated="2020-06-27">
        <ClinVarSubmissionID localKey="NC_000017.11:g.8076955_8076960del|MedGen:C3281200" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV001364140" DateUpdated="2020-06-27" DateCreated="2020-06-27" Type="SCV" Version="1" SubmitterName="Laboratory of Neurogenetics and Neuroinflammation, Institut Imagine" OrgID="507341" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-04-06">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SNORD118" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.11:g.8076955_8076960del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Leukoencephalopathy, brain calcifications, and cysts</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C3281200" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7247557</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2691558" TraitType="Disease" MappingType="Name" MappingValue="Leukoencephalopathy, brain calcifications, and cysts" MappingRef="Preferred">
        <MedGen CUI="C3281200" Name="Leukoencephalopathy with calcifications and cysts" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

